BAH vs SAIA

The Advanced Deterministic Scorecard reveals a mixed financial profile for BAH, with a weak Piotroski F-Score of 4/9 indicating marginal financial health, and no available Altman Z-Score to assess distress risk. Despite strong historical ROE of 75.2% and solid cash flow generation, the company faces significant headwinds with declining revenue and earnings, reflected in negative YoY growth of -8.1% and -52.9%, respectively. Valuation metrics suggest the stock is trading above its Graham Number of $35.57 and growth-based intrinsic value of $49.0, yet at a discount to sector peers on P/E. Analysts have a consensus 'hold' rating with a target price of $102.91, nearly at current levels, while technical trend signals remain bearish.

SAIA exhibits a strong operational foundation with a Piotroski F-Score of 8/9 and a very conservative debt profile (Debt/Equity 0.12). However, this fundamental health is decoupled from its market valuation, with the current price of $434.22 trading at a massive premium to both the Graham Number ($144.06) and the Intrinsic Value ($66.57). The investment thesis is further weakened by a severe earnings collapse (-37.60% YoY) and stagnant revenue growth (0.10%), suggesting the stock is priced for growth that is not currently manifesting. Bearish insider activity and a high PEG ratio (2.48) indicate significant downside risk.